These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10907460)

  • 1. Cytotoxic T lymphocyte priming versus cytotoxic T lymphocyte tolerance induction: a delicate balancing act involving dendritic cells.
    Melief CJ; Schoenberger S; Toes R; Offringa R
    Haematologica; 1999 Jun; 84 Suppl EHA-4():26-7. PubMed ID: 10907460
    [No Abstract]   [Full Text] [Related]  

  • 2. Gammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses.
    Xu Y; Kapp JA
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3473-9. PubMed ID: 12407158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen bias in T cell cross-priming.
    Wolkers MC; Brouwenstijn N; Bakker AH; Toebes M; Schumacher TN
    Science; 2004 May; 304(5675):1314-7. PubMed ID: 15166378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand-deficient mice.
    Walzer T; Brawand P; Swart D; Tocker J; De Smedt T
    J Allergy Clin Immunol; 2005 Jan; 115(1):192-9. PubMed ID: 15637568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA.
    Jung CW; Kwon JH; Seol JG; Park WH; Hyun JM; Kim ES; Kim ST; Lee SJ; Kim BK; Lee YY
    Am J Hematol; 2004 Mar; 75(3):121-7. PubMed ID: 14978690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein.
    Mincheff M; Zoubak S; Altankova I; Tchakarov S; Pogribnyy P; Makogonenko Y; Botev C; Meryman HT
    Cancer Gene Ther; 2005 Feb; 12(2):185-97. PubMed ID: 15375382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mini-review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming?
    Melief CJ
    Eur J Immunol; 2003 Oct; 33(10):2645-54. PubMed ID: 14515248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
    Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses.
    Smith SG; Patel PM; Porte J; Selby PJ; Jackson AM
    Clin Cancer Res; 2001 Dec; 7(12):4253-61. PubMed ID: 11751527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On cross-priming of MHC class I-specific CTL: rule or exception?
    Zinkernagel RM
    Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.
    Mehrotra S; Stevens R; Zengou R; Chakraborty NG; Butterfield LH; Economou JS; Dorsky DI; Mukherji B
    Cancer Res; 2003 Sep; 63(17):5607-14. PubMed ID: 14500402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of specific immune responses against the Plasmodium vivax liver-stage via in vitro activation by dendritic cells.
    Vichchathorn P; Jenwithisuk R; Leelaudomlipi S; Tungpradabkul S; Hongeng S; Cui L; Sattabongkot J; Udomsangpetch R
    Parasitol Int; 2006 Sep; 55(3):187-93. PubMed ID: 16793328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G
    Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escort service for cross-priming.
    Melief CJ
    Nat Immunol; 2005 Jun; 6(6):543-4. PubMed ID: 15908932
    [No Abstract]   [Full Text] [Related]  

  • 19. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
    Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
    Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.